KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hims & Hers Health (HIMS) Amortizatization of Intangibles (2020 - 2025)

Hims & Hers Health's Amortizatization of Intangibles history spans 6 years, with the latest figure at $719000.0 for Q4 2025.

  • For Q4 2025, Amortizatization of Intangibles fell 21.42% year-over-year to $719000.0; the TTM value through Dec 2025 reached $2.0 million, down 53.34%, while the annual FY2025 figure was $2.0 million, 53.34% down from the prior year.
  • Amortizatization of Intangibles for Q4 2025 was $719000.0 at Hims & Hers Health, up from $253000.0 in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $1.7 million in Q4 2023 and bottomed at -$1.2 million in Q3 2021.
  • The 5-year median for Amortizatization of Intangibles is $706000.0 (2025), against an average of $488050.0.
  • The largest annual shift saw Amortizatization of Intangibles plummeted 238.33% in 2022 before it surged 1333.33% in 2023.
  • A 5-year view of Amortizatization of Intangibles shows it stood at -$434000.0 in 2021, then soared by 293.55% to $840000.0 in 2022, then surged by 96.67% to $1.7 million in 2023, then plummeted by 44.61% to $915000.0 in 2024, then fell by 21.42% to $719000.0 in 2025.
  • Per Business Quant, the three most recent readings for HIMS's Amortizatization of Intangibles are $719000.0 (Q4 2025), $253000.0 (Q3 2025), and $367000.0 (Q2 2025).